COVID-19 studies for: C19 studies:  HC QHC Q IvermectinIVM Vitamin DVitamin D ZincZn REGN-COV2REGN LY-CoVLY RemdesivirRMD
HC Q study #149
Source   PDF   Share   Tweet
See all 181 studies
10/20
Negative
Late treatment study
Solh et al., medRxiv, doi:10.1101/2020.10.16.20214130 (Preprint)
Clinical course and outcome of COVID-19 acute respiratory distress syndrome: data from a national repository
Retrospective database analysis of 7,816 Veterans Affairs hospitalized patients analyzing progression to ARDS and 30-day mortality from ARDS. Confounding by indication is likely. Chronological bias is likely, with HC Q more likely to be used earlier on, before significant improvements in overall treatment.
No results are provided for HC Q for progression to ARDS.
death, ↑18.0%, p=0.17
Source   PDF   Share   Tweet
See all 181 studies
Please send us corrections, updates, or comments.
Submit